2020
DOI: 10.21037/tau.2019.12.19
|View full text |Cite
|
Sign up to set email alerts
|

Review of the evidence for robotic-assisted robotic cystectomy and intra-corporeal urinary diversion in bladder cancer

Abstract: Radical cystectomy, pelvic lymph node dissection and urinary diversion is the gold-standard treatment for muscle-invasive bladder cancer. The surgery is both complex and highly morbid. Robotic cystectomy is now in its 16 th year with established techniques and sufficient research maturity to enable comparison with its open counterpart. The present review focuses on the current evidence for robotic cystectomy and assesses various metrics including oncological, perioperative, functional, surgeon-specific and cos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 68 publications
0
3
0
Order By: Relevance
“…Other perioperative outcomes associated with the quality of surgery, including EBL, blood transfusion rate, and length of hospital stay (LOS), have been widely adopted in RARC [3].…”
Section: World Journal Of Clinical Surgerymentioning
confidence: 99%
See 1 more Smart Citation
“…Other perioperative outcomes associated with the quality of surgery, including EBL, blood transfusion rate, and length of hospital stay (LOS), have been widely adopted in RARC [3].…”
Section: World Journal Of Clinical Surgerymentioning
confidence: 99%
“…Recently, minimally invasive surgical approaches, including laparoscopic RC (LRC) and robotassisted RC (RARC), have been rapidly adopted for the treatment of MIBC, improving perioperative morbidity and the ease of recovery [2]. Although LRC cannot be widely implemented because of a prolonged learning curve and technically challenging procedure, RARC has been gradually adopted as a surgical treatment option for MIBC [3]. The RAZOR trial, a randomized open-label phase-III non-inferiority trial, demonstrated that RARC was non-inferior to open RC (ORC), based on 2-year progression-free survival rates [4].…”
Section: Introductionmentioning
confidence: 99%
“…Robot-assisted surgery is particularly beneficial in urology, where surgical dexterity is paramount for complex procedures. For example, robotic assistance can lead to fewer complications in cystectomy [1], along with other potential benefits [2]. It has also been shown that prostatectomy and nephrectomy benefit from robotic assistance [3,4].…”
mentioning
confidence: 99%